重组抗小鼠/人 CD11b单抗(M1/70.15.11.5.HL) | Syd Labs PA007544.r2b
Syd Labs体内实验级重组抗小鼠/人 CD11b 单克隆抗体,克隆号 M1/70.15.11.5.HL,恒定区为大鼠 IgG2b Kappa(Rat IgG2b Kappa),由哺乳动物细胞重组表达。CD11b(ITGAM,又称 Integrin alpha-M、Mac-1、CR3A、MO1A)是整合素 αM 链,与 β2 亚基(CD18)组成异二聚体 Mac-1(CR3,αMβ2),为 170 kDa I 型跨膜糖蛋白,主要表达于粒细胞、单核/巨噬细胞、髓系树突状细胞、NK 细胞、小胶质细胞及 B-1 B 细胞,介导与 ICAM-1(CD54)、ICAM-2(CD102)、纤维蛋白原及 iC3b 的黏附结合,是先天免疫、髓系细胞募集、吞噬、炎症与肿瘤微环境调控中的关键受体。M1/70.15.11.5.HL 源自经典抗 Mac-1 克隆 M1/70,可同时识别小鼠与人 CD11b,广泛用于流式细胞术、免疫组化、功能阻断(抑制 CR3 介导的黏附/玫瑰花环)及炎症、自身免疫、肿瘤免疫模型研究。本品经 Protein G 亲和纯化,还原性 SDS-PAGE 及 HPLC 检测纯度>95%,LAL 法内毒素<1 EU/mg,0.2 μM 过滤于 pH 7.4、不含稳定剂或防腐剂的 1× PBS 溶液,适用于 ELISA、中和实验、PK/ADA 等生物分析功能实验,以及受小鼠/人 CD11b 蛋白影响的生物学通路研究。
产品参数
| 货号 | PA007544.r2b |
|---|---|
| 产品名称 | 重组抗小鼠/人 CD11b单抗(M1/70.15.11.5.HL) | Syd Labs PA007544.r2b |
| 英文名 | In Vivo Grade Recombinant Anti-mouse/human CD11b Monoclonal Antibody (Clone: M1/70.15.11.5.HL), Rat IgG2b Kappa |
| 供货商名称 | Syd Labs, Inc. |
| 品牌名 | Syd Labs |
| 别称 | Mac-1, Integrin alpha-M, CR3A, ITGAM, MAC1A, MO1A, SLEB6 |
| 克隆号 | M1/70.15.11.5.HL |
| 同种型 | 大鼠 IgG2b Kappa |
| 特异性 | 该体内实验级重组大鼠单克隆抗体(克隆号 M1/70.15.11.5.HL)特异性结合小鼠/人 CD11b |
| 抗体形式 | 0.2 μM 过滤的溶液,pH 7.4,不含稳定剂或防腐剂 |
| 内毒素 | LAL 法测定,低于每 1 mg 蛋白 1 EU |
| 纯度 | 还原性条件下 SDS-PAGE 及 HPLC 检测>95% |
| 运输 | 采用冰袋运输;收到后请立即按下方推荐温度保存 |
| 稳定性与存储 | 使用手动除霜冰箱,避免反复冻融;自收货之日起 12 个月,按供货状态于 −20 ℃ 至 −70 ℃ 保存;自收货之日起 1 个月,按供货状态于 2 ℃ 至 8 ℃ 保存 |
| 产品咨询 | Syd Labs在国内只通过代理商销售其产品,不做直销。终端用户咨询价格请联系Syd Labs中国代理商。 关于Syd Labs产品如果有任何技术或其它问题,欢迎随时联系Syd Labs国内市场推广合作伙伴:武汉多找找科技有限公司,企业微信:duozhaozhao2024 联系电话:18162581039(龙经理) |
| 应用详情 | ELISA、中和实验、功能实验(如生物分析 PK 与 ADA 检测),以及研究受小鼠/人 CD11b 蛋白影响的生物学通路的实验 |
文献
PA007544.r2b: Syd Labs 重组抗小鼠/人 CD11b单克隆抗体(克隆号M1/70.15.11.5.HL) ,体内实验级重组,大鼠 IgG2b Kappa(In Vivo Grade Recombinant Anti-mouse/human CD11b Monoclonal Antibody (Clone: M1/70.15.11.5.HL), Rat IgG2b Kappa)
重组抗小鼠/人 CD11b单抗背景知识:
CD11b(基因名 ITGAM,蛋白又称 Integrin alpha-M、Mac-1、CR3A、MO1A)是整合素 αM 链,与 β2 链(CD18)非共价结合形成异二聚体 Mac-1(CR3,αMβ2,CD11b/CD18)。CD11b 是一种 170 kDa 的 I 型跨膜糖蛋白,含一个插入型结构域(I domain,又称 A 结构域),该结构域是配体识别的核心位点;CD11b 胞内段较短,主要经”由内向外”信号(inside-out signaling)发生构象活化,从低亲和力状态转为高亲和力状态。
CD11b 的表达谱以髓系细胞为主:中性粒细胞、单核/巨噬细胞、髓系树突状细胞、NK 细胞、小胶质细胞、嗜酸性粒细胞及 B-1 B 细胞表面均有表达,并在细胞活化后由胞内颗粒(分泌囊泡、明胶酶颗粒)快速转位至质膜、迅速上调表面表达。其经典配体包括 iC3b(补体片段,故 Mac-1 即补体受体 3)、ICAM-1(CD54)、ICAM-2(CD102)、纤维蛋白原、JAM-C,以及中性粒细胞同型黏附相关的反受体。
重组抗小鼠/人 CD11b单抗部分参考文献:
1. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody
Springer T, Galfré G, Secher DS, Milstein C
Eur J Immunol. 1979;9(4):301–306. PMID: 89016 DOI: 10.1002/eji.1830090410
“We have previously described the derivation of M1/70, a hybrid myeloma line secreting monoclonal rat anti-mouse cell surface antibody (Springer, T., Galfre, G., Secher, D. S. and Milstein, C, Eur. J. Immunol. 1978. 8: 539). We have now investigated the cellular distribution of this antigen using a 125I-labeled anti-rat IgG indirect binding assay, the fluorescence-activated cell sorter, autoradiography and precipitation of cell surface molecules. Screening with a tumor cell panel showed strong reactivity with a macrophage-like line but no reactivity with B or T lymphoma lines. In normal tissues, M1/70 antigen was found to be present in small amounts on spleen and exudate granulocytes and a subpopulation of bone marrow cells, in moderate amounts on spleen and blood monocytes and expressed in much larger amounts on spleen histiocytes and peritoneal exudate macrophages. In contrast, M1/70 antigen was found to be absent from erythroid and lymphoid cells. M1/70 antibody precipitated two polypeptides of 190 000 and 105 000 mol. wt. which were present in much greater amounts on peritoneal exudate macrophages than on spleen cells. The expression on phagocytes of two other antigens identified by monoclonal antibodies M1/69 and M1/9.3 was also examined. Monocytes and granulocytes expressed large amounts of M1/69 and low amounts of M1/70 antigen, while in peritoneal exudate macrophages this pattern was dramatically reversed. M1/70 thus defines a differentiation antigen on mononuclear phagocytes and granulocytes, the expression of which is specifically increased during monocyte maturation. This antibody is the first to be described which recognizes a discrete molecule specific to phagocytes.”
2.Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor
Beller DI, Springer TA, Schreiber RD
J Exp Med. 1982;156(4):1000–1009. PMID: 7153706 DOI: 10.1084/jem.156.4.1000
“Anti-Mac-1 (M1/70), a rat monoclonal antibody that reacts with mouse and human macrophages, polymorphonuclear leukocytes (PMNL), and natural killer cells, selectively inhibited complement receptor-mediated rosetting by murine macrophages and human PMNL. Preincubation of macrophages with anti-Mac-1 inhibited formation of rosettes with sheep erythrocytes bearing IgM antibody and murine C3 fragments. No inhibition was observed when other monoclonal antibodies that react with macrophages (such as anti-Ly5, anti-H-2, or anti-pan-leukocyte) were tested at 10-fold higher concentrations. Anti-Mac-1 did not affect macrophage Fc receptor-mediated rosetting. Erythrocytes bearing homogeneous human C3 fragments C3b (EC3b) or C3bi (EC3bi) were used to test the specificity of the murine macrophage and human PMNL complement receptor inhibited by anti-Mac-1. In both cases, anti-Mac-1 inhibited CR3-mediated rosetting of EC3bi but not CR1-dependent rosetting of EC3b. The results show that Mac-1 is either identical to CR3 or closely associated with CR3 function. This is one of the first cases in which a monoclonal antibody-defined differentiation antigen has been associated with a specific cell surface function.”
3.Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac-1 (complement receptor type 3)
Ding A, Wright SD, Nathan CF
J Exp Med. 1987;165(3):733–749. PMCID: PMC2188277 PMID: 3102677 DOI: 10.1084/jem.165.3.733
“Several features of activation of mouse peritoneal macrophages were elicited by 1-2-d exposure to submicrogram concentrations of anti-Mac-1 (M1/70), a rat monoclonal antibody that reacts with the alpha chain of complement receptor type 3 (Mac-1). The changes induced included enhanced capacity to secrete H2O2 when triggered with PMA, decreased secretion of proteins, increased expression of Ia antigen and decreased phagocytosis of particles. These changes closely resembled those induced by rIFN-gamma in type, extent, and time course. The concentration of M1/70 IgG resulting in 50% of the maximal activation of macrophage H2O2-releasing capacity averaged 0.18 +/- 0.03 micrograms/ml. This activation was not blocked by anti-FcR mAb, and could be reproduced with M18/2, a mAb against beta chain of Mac-1, suggesting that a direct ligation of Mac-1 with mAb was responsible for the activation. Neither depletion of T cells nor addition of neutralizing Abs to IFN-gamma or TNF-alpha prevented M1/70-mediated macrophage activation. Moreover, F(ab’)2 of M1/70, or plating of macrophages on C3bi-coated surfaces, inhibited the activation of macrophages by rIFN-gamma. These findings suggest that Mac-1 (CR3) may play an important role in macrophage activation.”
4.The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands
Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA
J Cell Biol. 1993;120(4):1031–1043. PMID: 8425901 DOI: 10.1083/jcb.120.4.1031
“Despite the identification and characterization of several distinct ligands for the leukocyte integrin (CD11/CD18) family of adhesion receptors, little is known about the structural regions on these molecules that mediate ligand recognition. In this report, we use alpha subunit chimeras of Mac-1 (CD11b/CD18) and p150,95 (CD11c/CD18), and an extended panel of newly generated and previously characterized mAbs specific to the alpha chain of Mac-1 to map the binding sites for four distinct ligands for Mac-1: iC3b, fibrinogen, ICAM-1, and the as-yet uncharacterized counter-receptor responsible for neutrophil homotypic adhesion. Epitopes of mAbs that blocked ligand binding were mapped with the chimeras and used to localize the ligand recognition sites because the data obtained from functional assays with the Mac-1/p150,95 chimeras were not easily interpreted. Results show that the I domain on the alpha chain of Mac-1 is an important recognition site for all four ligands, and that the NH2-terminal and perhaps divalent cation binding regions but not the COOH-terminal segment of the alpha subunit also contribute to ligand recognition. These results demonstrate that the I domain is a major recognition site for multiple ligands on Mac-1 and provide a structural framework for understanding integrin-ligand interactions.”
5.A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation
Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, Mayadas TN
Immunity. 1996;5(6):653–666. PMID: 8986723 DOI: 10.1016/S1074-7613(00)80278-2
“In mice selectively deficient in CD11b/CD18, a beta 2 integrin, chemoattractant-induced leukocyte adhesion to microvascular endothelium in vivo was reduced. Paradoxically, thioglycollate-induced neutrophil accumulation in the peritoneal cavity was increased and was associated with a significant delay in apoptosis of extravasated cells. The extravasated cells had a near absence of neutrophil phagocytosis and a reduction in oxygen free radical generation, which may contribute to the observed defect in apoptosis. This is supported by our in vitro studies, in which phagocytosis of opsonized particles by human neutrophils rapidly induced apoptosis that could be blocked with CD11b/CD18 antibodies. Reactive oxygen species are the intracellular link in this process: phagocytosis-induced apoptosis was blocked both in neutrophils treated with the flavoprotein inhibitor diphenylene iodonium and in neutrophils from patients with chronic granulomatous disease, which lack NADPH oxidase. Thus, CD11b/CD18 plays a novel and unsuspected homeostatic role in inflammation by accelerating the programmed elimination of extravasated neutrophils.”

